98-23131. Clinical Laboratory Improvement Advisory Committee (CLIAC): Meeting  

  • [Federal Register Volume 63, Number 167 (Friday, August 28, 1998)]
    [Notices]
    [Pages 46052-46053]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-23131]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    
    
    Clinical Laboratory Improvement Advisory Committee (CLIAC): 
    Meeting
    
        In accordance with section 10(a)(2) of the Federal Advisory 
    Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
    Prevention (CDC) announces the following committee meeting.
        Name: Clinical Laboratory Improvement Advisory Committee (CLIAC).
        Times and Dates: 8:30 a.m.-5 p.m., September 16, 1998; 8:30 a.m.-5 
    p.m., September 17, 1998.
        Place: CDC, Koger Center, Williams Building, Conference Rooms 1802 
    and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
        Status: Open to the public, limited only by the space available. 
    The meeting rooms accommodate approximately 85 people.
        Purpose: This committee is charged with providing scientific and 
    technical advice and guidance to the Secretary of Health and Human 
    Services, the Assistant Secretary for Health, and the Director, CDC, 
    regarding the need for, and the nature of, revisions to the standards 
    under which clinical laboratories are regulated; the impact of proposed 
    revisions to the standards; and the modification of the standards to 
    accommodate technological advances.
        Matters To Be Discussed: The agenda will include an update on CLIA 
    implementation; a report from the Genetic Testing Workgroup and 
    discussions of revisions to general or specific CLIA requirements that 
    apply to pre-analytic, analytic, and post-analytic components of 
    genetic testing; and the applicability of CLIA to laboratory testing 
    performed for assisted reproductive technology (ART).
        Agenda items are subject to change as priorities dictate.
    
    CONTACT PERSON FOR ADDITIONAL INFORMATION: John C. Ridderhof, Dr.
    
    [[Page 46053]]
    
    P.H., Division of Laboratory Systems, Public Health Practice Program 
    Office, CDC, 4770 Buford Highway, NE, Mailstop G-25, Atlanta, Georgia 
    30341-3724, telephone 770/488-8076, FAX 770/488-8282.
    
        Dated: August 24, 1998.
    Carolyn J. Russell,
    Director, Management Analysis and Services Office, Centers for Disease 
    Control and Prevention (CDC).
    [FR Doc. 98-23131 Filed 8-27-98; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
08/28/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
98-23131
Dates:
8:30 a.m.-5 p.m., September 16, 1998; 8:30 a.m.-5 p.m., September 17, 1998.
Pages:
46052-46053 (2 pages)
PDF File:
98-23131.pdf